ETV5 as a regulator of matrix metalloproteinase 2 in human chondrosarcoma

Journal of Orthopaedic Research

Volumn 31, Issue 3, 2013, Pages 493-501

  Power, Patricia F ^a,b   Mak, Isabella W Y ^a,b   Singh, Shalini ^a,b   Popovic, Snezana ^a   Gladdy, Rebecca ^c   Ghert, Michelle ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b JURAVINSKI CANCER CENTRE   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

bone resorption; collagen; gelatinase; metastasis; transcription factor

Indexed keywords

COLLAGEN TYPE 1; COMPLEMENTARY DNA; GELATINASE A; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETV5; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CASE REPORT; CHONDROSARCOMA; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IN VIVO STUDY; MALE; OSTEOLYSIS; PLASMID; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR CELL; WESTERN BLOTTING;

BONE NEOPLASMS; BONE RESORPTION; CELL LINE; CELL LINE, TUMOR; CHONDROSARCOMA; COLLAGEN; DNA-BINDING PROTEINS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; OSTEOBLASTS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 84872815895     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22227     Document Type: Article

References (37)

1. Capps E, Shiller SM, Cheek S, et al. 2009. Chest wall chondrosarcoma. Proc (Bayl Univ Med Cent) 22: 362-365. Epub 2009/10/01.
2. Onishi AC, Hincker AM, Lee FY,. 2011. Surmounting chemotherapy and radioresistance in chondrosarcoma: molecular mechanisms and therapeutic targets. Sarcoma 2011: 381564. Epub 2011/01/15.
3. Zyada MM, Shamaa AA,. 2008. Is collagenase-3 (MMP-13) expression in chondrosarcoma of the jaws a true marker for tumor aggressiveness? Diagn Pathol 3: 26. Epub 2008/06/17.
4. Bovee JV, Hogendoorn PC, Wunder JS, et al. 2010. Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. Nat Rev Cancer 10: 481-488. Epub 2010/06/11.
5. Clark JC, Akiyama T, Dass CR, et al. 2010. New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis. Cancer Cell Int 10: 20. Epub 2010/06/30.
6. Lechler P, Renkawitz T, Campean V, et al. 2011. The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro. BMC Cancer 11: 120. Epub 2011/04/05.
7. Rizzo M, Ghert MA, Harrelson JM, et al. 2001. Chondrosarcoma of bone: analysis of 108 cases and evaluation for predictors of outcome. Clin Orthop Relat Res 391: 224-233. Epub 2001/10/18.
8. Rozeman LB, Cleton-Jansen AM, Hogendoorn PC,. 2006. Pathology of primary malignant bone and cartilage tumours. Int Orthop 30: 437-444. Epub 2006/09/01.
9. Kim DW, Seo SW, Cho SK, et al. 2007. Targeting of cell survival genes using small interfering RNAs (siRNAs) enhances radiosensitivity of Grade II chondrosarcoma cells. J Orthop Res 25: 820-828. Epub 2007/03/09.
10. Sternlicht MD, Werb Z,. 2001. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516. Epub 2001/11/01.
11. Lindstad RI, Sylte I, Mikalsen SO, et al. 2005. Pancreatic trypsin activates human promatrix metalloproteinase-2. J Mol Biol 350: 682-698. Epub 2005/06/14.
12. Durrant JD, de Oliveira CA, McCammon JA,. 2010. Including receptor flexibility induced fit effects into the design of MMP-2 inhibitors. J Mol Recognit 23: 173-182. Epub 2009/11/03.
13. Oikawa T,. 2004. ETS transcription factors: possible targets for cancer therapy. Cancer Sci 95: 626-633. Epub 2004/08/10.
14. Stamenkovic I,. 2000. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 10: 415-433. Epub 2001/02/15.
15. Cowan RW, Mak IW, Colterjohn N, et al. 2009. Collagenase expression and activity in the stromal cells from giant cell tumour of bone. Bone 44: 865-871. Epub 2009/05/16.
16. Rabinovich A, Mak IW, Cowan RW, et al. 2009. Matrix metalloproteinase activity in the stromal cell of giant cell tumor of bone. Open Bone J 1: 46-52. Epub 2009/10/01.
17. Chen YC, Sosnoski DM, Mastro AM,. 2010. Breast cancer metastasis to the bone: mechanisms of bone loss. Breast Cancer Res 12: 215. Epub 2010/12/24.
18. Dong Z, Bonfil RD, Chinni S, et al. 2005. Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue. Am J Pathol 166: 1173-1186. Epub 2005/03/29.
19. Soderstrom M, Aro HT, Ahonen M, et al. 2001. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas. APMIS 109: 305-315. Epub 2001/07/27.
20. Monge M, Colas E, Doll A, et al. 2007. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer. Cancer Res 67: 6753-6759. Epub 2007/07/20.
21. Jedlicka P, Gutierrez-Hartmann A,. 2008. Ets transcription factors in intestinal morphogenesis, homeostasis and disease. Histol Histopathol 23: 1417-1424. Epub 2008/09/12.
22. Firlej V, Ladam F, Brysbaert G, et al. 2008. Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription. J Cell Sci 121: 3393-3402. Epub 2008/10/02.
23. Tomlins SA, Laxman B, Varambally S, et al. 2008. Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia 10: 177-188. Epub 2008/02/20.
24. Vitari AC, Leong KG, Newton K, et al. 2011. COP1 is a tumour suppressor that causes degradation of ETS transcription factors. Nature 474: 403-406. Epub 2011/05/17.
25. Cao S, Xiang Z, Ma X,. 2004. Global gene expression profiling in interleukin-12-induced activation of CD8(+) cytotoxic T lymphocytes against mouse mammary Carcinoma. Cell Mol Immunol 1: 357-366. Epub 2005/11/16.
26. Khalili A, Potter D, Yan P, et al. 2007. Gamma-normal-gamma mixture model for detecting differentially methylated loci in three breast cancer cell lines. Cancer Inform 3: 43-54. Epub 2007/01/01.
27. Xu J, Wu RC, O'Malley BW,. 2009. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer 9: 615-630. Epub 2009/08/25.
28. Bieche I, Tozlu S, Girault I, et al. 2004. Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expression. Carcinogenesis 25: 405-411. Epub 2003/11/25.
29. Qin L, Liao L, Redmond A, et al. 2008. The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression. Mol Cell Biol 28: 5937-5950. Epub 2008/07/23.
30. Planaguma J, Liljestrom M, Alameda F, et al. 2011. Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma. Hum Pathol 42: 57-67. Epub 2010/10/26.
31. de Launoit Y, Baert JL, Chotteau-Lelievre A, et al. 2006. The Ets transcription factors of the PEA3 group: transcriptional regulators in metastasis. Biochim Biophys Acta 1766: 79-87. Epub 2006/03/21.
32. Bruni-Cardoso A, Johnson LC, Vessella RL, et al. 2010. Osteoclast-derived matrix metalloproteinase-9 directly affects angiogenesis in the prostate tumor-bone microenvironment. Mol Cancer Res 8: 459-470. Epub 2010/03/25.
33. Lai TJ, Hsu SF, Li TM, et al. 2007. Alendronate inhibits cell invasion and MMP-2 secretion in human chondrosarcoma cell line. Acta pharmacol Sin 28: 1231-1235. Epub 2007/07/21.
34. Chen C, Ouyang W, Grigura V, et al. 2005. ERM is required for transcriptional control of the spermatogonial stem cell niche. Nature 436: 1030-1034. Epub 2005/08/19.
35. Hofmann MC,. 2008. Gdnf signaling pathways within the mammalian spermatogonial stem cell niche. Mol Cell Endocrinol 288: 95-103. Epub 2008/05/20.
36. Oatley JM, Avarbock MR, Brinster RL,. 2007. Glial cell line-derived neurotrophic factor regulation of genes essential for self-renewal of mouse spermatogonial stem cells is dependent on Src family kinase signaling. J Biol Chem 282: 25842-25851. Epub 2007/06/29.
37. Mak IW, et al. 2010. Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone. Hum Pathol 41: 1320-1329.